Corticotropin-releasing factor mRNA and substance P receptor binding in the paraventricular hypothalamic nucleus, central nucleus of the amygdala, and locus coeruleus of Sprague-Dawley rats following restraint-induced stress

被引:29
作者
Hwang, BH [1 ]
Katner, J
Iyengar, S
机构
[1] Indiana Univ, Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
关键词
corticotropin-releasing factor (CRF) mRNA; substance P (SP) binding; central nucleus of the amygdala (CeA); locus coeruleus (LC); paraventricular hypothalamic nucleus (PVN);
D O I
10.1385/JMN:25:3:239
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The central mechanism of stress is poorly understood. This study was designed to examine how corticotropin-releasing factor (CRF) neurons, together with substance P (SP) receptors in the paraventricular hypothalamic nucleus (PVN), central nucleus of the amygdala (CeA), and locus coeruleus (LC), are affected by stress. Sprague-Dawley rats were restrained for 2 h. Animals were sacrificed by decapitation immediately after the 2-h restraint (the 0-h group) and 4, 24, or 48 h after restraint. Tissue sections were cut and collected on two sets of slides. Tissue sections of the first set were processed for studying CRF mRNA using P-33-labeled 60-mer oligonucleotide probe. Immediately adjacent tissue sections were processed for studying SP receptor-binding capacity using I-125-SP ligand. Quantitative results showed that CRF mRNAs in the PVN were significantly up-regulated at the 4- and 24-h stages, and they seemed not to be regulated by SP receptors. In addition, SP receptors in the CeA were up-regulated at the 24- and 48-h stages, whereas SP receptors were down-regulated in the LC at the same stages. In concert with the literature indicating SP antagonist's antidepressive effects, up-regulated SP receptors in the CeA might contribute to the development of stress-related depression.
引用
收藏
页码:239 / 250
页数:12
相关论文
共 73 条
[1]
Albeck DS, 1997, J NEUROSCI, V17, P4895
[2]
[Anonymous], STRESS NEUROBIOLOGY
[3]
ASTONJONES G, 1981, J NEUROSCI, V1, P887
[4]
Substance P antagonists: the next breakthrough in treating depression? [J].
Baby, S ;
Nguyen, M ;
Tran, D ;
Raffa, RB .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1999, 24 (06) :461-469
[5]
BRODY MJ, 1988, CLIN PHYSIOL BIOCH, V6, P230
[6]
THE DOPAMINERGIC INNERVATION OF THE SUPRAOPTIC AND PARAVENTRICULAR NUCLEUS - A LIGHT AND ELECTRON MICROSCOPICAL STUDY [J].
BUIJS, RM ;
GEFFARD, M ;
POOL, CW ;
HOORNEMAN, EMD .
BRAIN RESEARCH, 1984, 323 (01) :65-72
[7]
Chowdhury GMI, 2000, BRAIN RES BULL, V52, P171
[8]
Substance P (neurokinin 1) receptor antagonists enhance dorsal raphe neuronal activity [J].
Conley, RK ;
Cumberbatch, MJ ;
Mason, GS ;
Williamson, DJ ;
Harrison, T ;
Locker, K ;
Swain, C ;
Maubach, K ;
O'Donnell, R ;
Rigby, M ;
Hewson, L ;
Smith, D ;
Rupniak, NMJ .
JOURNAL OF NEUROSCIENCE, 2002, 22 (17) :7730-7736
[9]
CULMAN J, 1991, Endocrine Regulations, V25, P151
[10]
ANATOMICAL SPECIFICITY OF NORADRENERGIC INPUTS TO THE PARAVENTRICULAR AND SUPRAOPTIC NUCLEI OF THE RAT HYPOTHALAMUS [J].
CUNNINGHAM, ET ;
SAWCHENKO, PE .
JOURNAL OF COMPARATIVE NEUROLOGY, 1988, 274 (01) :60-76